Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of YZJ-4729 tartrate injection for postoperative abdominal surgery analgesia
ChiCTR2300075218Phase 2Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of YZJ-4729 in postoperative pain (6 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: NRS pain intensity score and Summed pain intensity difference (SPID). Started Aug 2023; status: recruiting.
02
Drugs
YZJ-4729
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300075218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075218.